A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma who Have Received at Least 1 Prior Line of Therapy
- Ganguly, Siddhartha (PI)
- Petkova, Jenny (Key Personnel)
- Pingali, S. Ravi (Key Personnel)
- Shah, Shilpan (Key Personnel)
Project: Clinical Trial